As of 2024-12-15, the Fair Value of Turning Point Therapeutics Inc (TPTX) is -34.46 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 76.01 USD, the upside of Turning Point Therapeutics Inc is -145.34%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -24.79 | -72.13 | -157.29 | -236.55 | -122.69 | |
| YoY growth | -49.43% | -190.96% | -118.06% | -50.39% | -102.21% | |
| Market Cap (mil) | 3,775.14 |
| P/E | |
| Forward P/E | -11.00x |
| EPS | -6.89 |
| Avg earnings growth rate | -102.21% |
| TTM earnings | -342.31 |